Compare Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) vs Teucrium Soybean Fund (SOYB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio-Rad Laboratories, Inc. Class A Common Stock vs Teucrium Soybean Fund — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $356.44 (market cap $9.43B), while Teucrium Soybean Fund trades at $24.82. The key difference: Bio-Rad Laboratories, Inc. Class A Common Stock is trading nearer its 52-week high, Teucrium Soybean Fund nearer its low. Which is the better fit depends on your goals.
| BIO | SOYB | |
|---|---|---|
Market Cap | $9.43B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $356.25 | $26.28 |
52-Week Low | $241.71 | $21.46 |
Enterprise Value | $9.18B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SOYB trades at $25.04, showing minimal daily change of 0.03%. Technical indicators suggest a bearish bias with moving averages signaling caution, though oscillators are neutral. Recent news highlights potential agricultural sector tailwinds from China's $17 billion crop purchase pledge through 2028, which could benefit U.S. exporters like SOYB. However, key financial ratios including P/E, P/S, and profitability metrics are currently unavailable, limiting fundamental clarity.
The stock faces near-term technical headwinds but may find support from positive agricultural trade developments. Investment opportunity hinges on improved financial disclosure and sector momentum, while risks include geopolitical tensions and lack of transparent fundamentals. Investors require updated earnings reports to assess valuation properly.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bio-Rad Laboratories, Inc. Class A Common Stock
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →About Teucrium Soybean Fund
SOYB is a commodity ETF that provides exposure to the price of soybean futures. It utilizes a laddered strategy by investing in several benchmark futures contracts to reduce the impact of roll costs and contango in the agricultural market.
Read more on SOYB →
